Karen Mossman

Karen Mossman

McMaster University

H-index: 70

North America-Canada

About Karen Mossman

Karen Mossman, With an exceptional h-index of 70 and a recent h-index of 42 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Molecular Virology, Innate Immunity, Oncolytic Viruses.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera

Immunological features of bats: resistance and tolerance to emerging viruses

Fatal attractions that trigger inflammation and drive atherosclerotic disease

Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells

Method for treating viral infections using ask1 inhibitors

ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2

Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R. 1 Lineage Variants, Canada

Karen Mossman Information

University

Position

Professor of Pathology and Molecular Medicine

Citations(all)

13983

Citations(since 2020)

6987

Cited By

9513

hIndex(all)

70

hIndex(since 2020)

42

i10Index(all)

132

i10Index(since 2020)

109

Email

University Profile Page

Google Scholar

Karen Mossman Skills & Research Interests

Molecular Virology

Innate Immunity

Oncolytic Viruses

Top articles of Karen Mossman

A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera

The Journal of Immunology

2024/4/29

Immunological features of bats: resistance and tolerance to emerging viruses

2024/3/1

Karen Mossman
Karen Mossman

H-Index: 39

Fatal attractions that trigger inflammation and drive atherosclerotic disease

2024/1/29

Karen Mossman
Karen Mossman

H-Index: 39

Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells

Journal for Immunotherapy of Cancer

2024

Method for treating viral infections using ask1 inhibitors

2023/12/7

ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2

Antiviral Research

2023/12/1

Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer

2023/7/27

Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R. 1 Lineage Variants, Canada

Emerging Infectious Diseases

2023/7

Detection of Large Genomic RNA via DNAzyme‐Mediated RNA Cleavage and Rolling Circle Amplification: SARS‐CoV‐2 as a Model

Chemistry–A European Journal

2023/5/11

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

Cancers

2023/2/17

Altered microRNA transcriptome in cultured human airway cells upon infection with SARS-CoV-2

Viruses

2023/2/10

Karen Mossman
Karen Mossman

H-Index: 39

Patrick Provost
Patrick Provost

H-Index: 28

Differential Cellular Sensing of Fusion from within and Fusion from without during Virus Infection

Viruses

2023/1/21

Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1

Journal for Immunotherapy of Cancer

2023

Laying the foundation for single-cell studies in bats

Immunity

2022/11/8

Karen Mossman
Karen Mossman

H-Index: 39

Human coronaviruses disassemble processing bodies

PLoS pathogens

2022/8/23

Danyel Evseev
Danyel Evseev

H-Index: 3

Karen Mossman
Karen Mossman

H-Index: 39

Visualizing Early HCoV-229E Viral Infection Events Using Correlative 2D Light and 3D Electron Microscopy Techniques

Microscopy and Microanalysis

2022/8

Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways

Iscience

2022/7/15

IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity

Molecular Therapy-Oncolytics

2022/6/16

Covalent immune proximity-induction strategy using SuFEx-engineered bifunctional viral peptides

ACS Chemical Biology

2022/5/6

See List of Professors in Karen Mossman University(McMaster University)